Latest Etonogestrel Stories

Resource4thePeople's national network of attorneys offers free consultations over legal options that may be available to women alleging they may have suffered blood-clotting problems from use of NuvaRing contraceptive. San Diego, CA (PRWEB) May 02, 2013 http://www.resource4thepeople.com/defectivedrugs/nuvaring.html Resource4thePeople announced today its latest update of state and federal NuvaRing lawsuits alleging that women who used the popular contraceptive allegedly suffered...

U.S. District Judge in Missouri decides more time is needed before first trial over whether the intrauterine device puts women in danger of suffering life-threatening blood clots. Resource4thePeople continuing to provide legal consultations. San Diego CA (PRWEB) March 02, 2013 In its latest update to consumers about the progress of more than 1,000 lawsuits involving claims that the NuvaRing contraceptive puts women at higher risk of blood clotting, Resource4thePeople is reporting today...

Court records show that more than 1,000 cases have been filed so far in federal consolidated litigation San Diego CA (PRWEB) February 09, 2013 http://www.resource4thepeople.com/defectivedrugs/nuvaring.html Resource4thePeople announced today that as the number of lawsuits filed by victims who claim blood-clotting problems as a result of their use of the NuvaRing contraceptive has climbed to more than 1,000* it is continuing to provide referrals for victims of these side effects to lawyers...

CRESSKILL, N.J., Jan. 11, 2013 /PRNewswire/ -- The trial date for over 1,000 NuvaRing lawsuits is being extended, feeding rumors that the vaginal ring contraceptive's manufacturer, Merck, may be ready to enter settlement negotiations. The lawsuits allege that NuvaRing caused serious side effects, including blood clots, deep vein thrombosis, pulmonary embolism, heart attacks, strokes, and wrongful death. The multidistrict litigation before Rodney W. Sippel of the U.S. District Court,...

OAKLAND, Calif., Oct. 18, 2012 /PRNewswire/ -- A U.S. Food and Drug Administration-funded study led by the Kaiser Permanente Northern California Division of Research found an increased risk of arterial thrombotic events (ATE) and venous thromboembolic events (VTE) -- commonly referred to as blockage of arteries and blood clots, respectively -- associated with drospirenone-containing birth control pills compared to four low-dose estrogen combined hormonal contraceptives. The study...

NuvaRing Lawsuit Alleges Merck & Co., Organon USA, Inc., and other Defendants Failed to Warn Plaintiff of Serious NuvaRing Side Effects, Including a Higher Risk of Clots, Such as Deep Vein Thrombosis and Pulmonary Embolism, Compared to Birth Control Pills. Mellville, New York (PRWEB) September 24, 2012 Alonso Krangle LLP, an national law firm focused on fighting for the rights of serious personal injury victims of harmful drug side effects, announce they have filed a NuvaRing side...

According to the study published on May 10th 2012 in the British Medical Journal, non-oral contraceptives, including NuvaRing, have a higher risk of blood clots than combined oral contraceptives (COCs) based on oestrogens and progestins. NuvaRing, approved by the FDA in 2001, is a contraceptive that comes in the form of a vaginal ring using female hormones in an effort to prevent ovulation. Women who used a vaginal ring had a 6.5 times higher risk for developing blood clots compared to...

Finding suggest some women should shift to a contraceptive pill to reduce their risk A study published on bmj.com today adds to the evidence that certain non-oral hormonal contraceptives (e.g. skin patches, implants and vaginal rings) carry a higher risk of serious blood clots (known as venous thromboembolism) than others. The findings suggest that some women should switch from a non-oral product to a contraceptive pill to help reduce their risk. Several studies have assessed the...

According to court documents filed on February 28th, 2012, New Jersey state court Judge Brian Martinotti, who is presiding over the NJ Mass Tort for NuvaRing cases (BER-L-3081-09) stated that it is anticipated by the Court that all nine of the selected "bellwether" cases will be ready to be tried on February 4th, 2013. Over in the federal court system, Judge Rodney Sippel has not yet established a firm date for the first trial in the NuvaRing MDL litigation (MDL 1964). NuvaRing...

(Ivanhoe Newswire) – Drospirenone-containing oral birth control pills are linked to a significantly higher risk of blood clots, both deep vein thrombosis and pulmonary embolism, according to this study. All oral contraceptives are associated with a higher risk of blood clots, but there is conflicting information about the risk of adverse events with drospirenone. Many previous studies have evaluated risks of second- and third-generation contraceptives, which both contain derivatives of...